Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Promoting better cardiovascular health
Your prescriber may recommend switching based on your evolving health goals
empty stomach Pre-filled pen, no reconstitution needed Safety Comparison# Both agents share the GLP-1 agonist class side effect profile: nausea, vomiting, diarrhea, constipation, and abdominal pain, predominantly during dose escalation
Following the results of the SELECT trial, the FDA approved a new indication for Wegovy (semaglutide) in March 2024: to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight
Before starting weight loss injections , arrange a consultation with your GP if you: Have known gallstones or previous gallbladder problems Have a family history of gallstone disease Have experienced unexplained abdominal pain Are considering rapid weight loss for any reason Have multiple risk factors for gallstones (female sex, age over 40, obesity, rapid previous weight loss) Your doctor will take a comprehensive medical history, perform an examination, and may arrange investigations such as liver function tests or an abdominal ultrasound (the first-line imaging test according to NICE CG188) to assess your gallbladder before recommending treatment options
US$ 23.22
)
US$ 24.27
US$ 23.41
)
US$ 20.37
)
